109 related articles for article (PubMed ID: 17435680)
1. Genetic background of carcinogenesis in the thyroid gland.
Lewiński A; Wojciechowska K
Neuro Endocrinol Lett; 2007 Apr; 28(2):77-105. PubMed ID: 17435680
[TBL] [Abstract][Full Text] [Related]
2. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of thyroid neoplasms.
Satta MA; Nanni S; Della Casa S; Pontecorvi A
Rays; 2000; 25(2):151-61. PubMed ID: 11370534
[TBL] [Abstract][Full Text] [Related]
4. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin receptor: a role for thyroid tumourigenesis?
Russo D; Arturi F; Chiefari E; Filetti S
Forum (Genova); 1999; 9(2):166-75. PubMed ID: 10385711
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
7. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
8. An epitome of DNA repair related genes and mechanisms in thyroid carcinoma.
Gatzidou E; Michailidi C; Tseleni-Balafouta S; Theocharis S
Cancer Lett; 2010 Apr; 290(2):139-47. PubMed ID: 19709803
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of thyroid nodules and cancer.
Moretti F; Nanni S; Pontecorvi A
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):517-39. PubMed ID: 11289733
[TBL] [Abstract][Full Text] [Related]
10. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
[TBL] [Abstract][Full Text] [Related]
11. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
12. Thyroid tumorigenesis and molecular markers in thyroid cancer.
Kouniavsky G; Zeiger MA
Curr Opin Oncol; 2010 Jan; 22(1):23-9. PubMed ID: 19907326
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
Cerrato A; De Falco V; Santoro M
J Mol Endocrinol; 2009 Oct; 43(4):143-55. PubMed ID: 19383830
[TBL] [Abstract][Full Text] [Related]
14. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract][Full Text] [Related]
16. [Geographical differences of thyroid carcinoma and basic molecular principles].
Goretzki PE; Witte J; Dotzenrath C; Schulte KM; Simon D; Röher HD
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():200-2. PubMed ID: 9931611
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in gallbladder carcinoma.
Kuroki T; Tajima Y; Matsuo K; Kanematsu T
Surg Today; 2005; 35(2):101-5. PubMed ID: 15674488
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations in thyroid cancer: the role of mouse models.
Knostman KA; Jhiang SM; Capen CC
Vet Pathol; 2007 Jan; 44(1):1-14. PubMed ID: 17197619
[TBL] [Abstract][Full Text] [Related]
19. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
[TBL] [Abstract][Full Text] [Related]
20. Intragenic mutations in thyroid cancer.
Sobrinho-Simões M; Máximo V; Rocha AS; Trovisco V; Castro P; Preto A; Lima J; Soares P
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):333-62, viii. PubMed ID: 18502330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]